Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

ECG abnormalities can predict COVID-19 mortality

A team of scientists from New York University Langone Medical Center, USA, has revealed that the clinical severity of hospitalized patients with coronavirus disease 2019 (COVID-19) can be predicted by analyzing the level of troponin elevation and electrocardiographic (ECG) abnormalities. The study is currently available on the medRxiv preprint server.

17 Nov 2020

UCLA researchers pinpoint how smoking causes more severe COVID-19 infection

UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes COVID-19, in the airways of the lungs.

17 Nov 2020

Goblet cells are prime target for SARS-CoV-2, study finds

A recent study reports that in the airway of patients with chronic obstructive pulmonary disease (COPD), a type of airway epithelial cell – called a goblet cell – presents a prime target for the virus and plays a vital role in promoting viral replication in this tissue.

16 Nov 2020

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Scientists in Taiwan recently published a report on their use of anti-neutrophil strategies to treat acute respiratory distress syndrome (ARDS) – a life-threatening condition that can arise in critical COVID-19 cases – in the journal Frontiers in Pediatrics.

15 Nov 2020

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Now, a team of researchers at the Synairgen Research, Southampton General Hospital, Southampton, United Kingdom, has found that inhaled nebulized interferon beta-1a (SNG001), a drug used for multiple sclerosis, helped COVID-19 patients have greater odds of improvement and recovery from SARS-CoV-2 infection.

15 Nov 2020

Study: E-cigarette users have 43% increased risk of developing respiratory disease

A growing body of evidence points to the health risks of using e-cigarettes (or "vaping"). But because e-cigarettes are marketed as a less harmful alternative to traditional cigarettes, it has been difficult to tell whether the association between vaping and disease is just a matter of smokers switching to vaping when they start experiencing health issues.

12 Nov 2020

Researchers design implantable sensor to measure bodily functions

Sensors that monitor a patient's condition during and after medical procedures can be expensive, uncomfortable and even dangerous.

10 Nov 2020

Exosome-mediated mRNA delivery generates broad immune response to multiple SARS-CoV-2 proteins

Recently, researchers from The Johns Hopkins University School of Medicine, Baltimore, MD, USA, and Capricor Therapeutics, Inc., Beverly Hills, CA, USA, described a new approach to SARS-CoV-2 vaccine development using exosomes to deliver mRNAs that encode the antigens from multiple structural proteins of the virus.

9 Nov 2020

Study examines if patient-generated online physician reviews reflect the quality of care

Online consumer reviews play an important role in almost every consumer industry -- from dining and shopping to travel and technology. But what do online reviews of physicians tell consumers?

9 Nov 2020

Melatonin may be a viable treatment option for COVID-19, study suggests

Results from a new Cleveland Clinic-led study suggest that melatonin, a hormone that regulates the sleep-wake cycle and is commonly used as an over-the-counter sleep aid, may be a viable treatment option for COVID-19.

9 Nov 2020

Innate immunity key to limiting viral load in COVID-19 cases

As the coronavirus disease 2019 (COVID-19) pandemic continues to cause many difficulties for public health authorities, research is ongoing to understand how the virus can cause fatal effects on those infected and thereby suggest effective preventive and therapeutic measures against it.

8 Nov 2020

COVID-19 hospitalizations and deaths skew towards older males of non-European ancestry

A team of researchers recently investigated the genetic determinants of COVID-19 risk and severity in humans.

6 Nov 2020

Researchers develop novel therapeutic approach against COPD

Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

4 Nov 2020

Primary care for acute health conditions declined dramatically since UK lockdown

Researchers have conducted a study showing substantial reductions in the number of people attending primary care services for key physical and mental health conditions in the UK since lockdown was introduced on March 23rd this year.

3 Nov 2020

Lung biomarkers may predict severe COVID-19

Two University of New Mexico researchers postulate certain specific biomarkers' relevance in predicting the potential for progression to severe COVID-19 in a paper published on the preprint server bioRxiv*

27 Oct 2020

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

A recent study published on the preprint server bioRxiv in October 2020 shows that in patients with chronic lung disease, the pattern of gene expression in the different types of cell changes such that the lung epithelium is prepared to tackle SARS-CoV-2 infection. Also, the altered gene programs have an impact on the immune response.

22 Oct 2020

First COPD patient treated with RejuvenAir System in a multicenter clinical trial

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir System for the treatment of patients suffering from moderate to severe chronic obstructive pulmonary disease with chronic bronchitis.

21 Oct 2020

AncestryDNA modeling study of 500,000 Americans sheds light on COVID-19 risk factors

Now, a new study by researchers at AncestryDNA, a company that provides DNA testing services that use modern autosomal testing technology, shows that some people are more susceptible to COVID-19 infection, and they may experience more severe outcomes, including males, the elderly, and those with comorbidities.

14 Oct 2020

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

A large, international study of COVID-19 patients confirmed that cardiovascular disease, hypertension, diabetes, congestive heart failure, chronic kidney disease, stroke and cancer can increase a patient's risk of dying from the virus.

8 Oct 2020

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

ECG abnormalities can predict COVID-19 mortality

UCLA researchers pinpoint how smoking causes more severe COVID-19 infection

Goblet cells are prime target for SARS-CoV-2, study finds

Drugs targeting neutrophils could reduce ARDS in severe COVID-19

Inhaled nebulized interferon beta-1a (SNG001) helps COVID-19 patients recovers

Study: E-cigarette users have 43% increased risk of developing respiratory disease

Researchers design implantable sensor to measure bodily functions

Exosome-mediated mRNA delivery generates broad immune response to multiple SARS-CoV-2 proteins

Study examines if patient-generated online physician reviews reflect the quality of care

Melatonin may be a viable treatment option for COVID-19, study suggests

Innate immunity key to limiting viral load in COVID-19 cases

COVID-19 hospitalizations and deaths skew towards older males of non-European ancestry

Researchers develop novel therapeutic approach against COPD

Primary care for acute health conditions declined dramatically since UK lockdown

Lung biomarkers may predict severe COVID-19

Researchers assess molecular basis of SARS-CoV-2 severity and poor outcomes in lung disease

First COPD patient treated with RejuvenAir System in a multicenter clinical trial

AncestryDNA modeling study of 500,000 Americans sheds light on COVID-19 risk factors

Analysis of existing comorbidities and COVID-19 mortality

Certain pre-existing conditions may highly increase a patient's risk of dying from COVID-19

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chronic Obstructive Pulmonary Disease News and Research

Latest Chronic Obstructive Pulmonary Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in